Moody's Investors Service has assigned a "Ba1" rating to Escondido, Calif.-based Palomar Health's proposed series 2016 refunding revenue bonds, which will have a par value of approximately $252 million.
The outlook remains stable.
The "Ba1" rating affirmation and maintenance of the stable outlook reflects Palomar Health's improved operating performance and growing cash measures.
Moody's also affirmed the "Ba1" rating on Palomar Health's parity revenue bonds worth $550 million.